Answers are grounded in this paper and cite their sources.
The dynamic, sequential progression of lung adenocarcinoma (LUAD) from adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), to invasive adenocarcinoma (IAC) involves changes in genomics, proteomics, and the tumor microenvironment (TME). RNA-binding proteins (RBPs), as key factors linking gene expression and protein phenotype stability, play a crucial role in the development and progression of human cancers. However, a systematic study of RNA-binding proteins during LUAD invasion has yet to be elucidated. Here, we characterized 28 RNA-binding proteins that are upregulated during LUAD invasion using single-cell transcriptomics data. To identify promising therapeutic targets and biomarkers, we systematically screened these RBPs using machine learning and established a prognostic risk model. This model effectively predicted overall survival in LUAD patients. Further analysis using SHapley additive interpretation (SHAP) revealed that HSPD1 significantly contributes to the survival disadvantage of high-risk patients and can serve as an independent prognostic factor for LUAD. Cell communication analysis and cell function experiments revealed that HSPD1 promotes lung adenocarcinoma invasion and immune microenvironment remodeling through MIF signaling, activating the AKT/ERK pathway. Therefore, our findings contribute to a deeper understanding of the molecular mechanisms underlying the progression of lung adenocarcinoma from AIS to IAC, laying a theoretical foundation for the development of precision medicine for LUAD.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: